**Core Concept**
The treatment of multi-drug resistant tuberculosis (MDR-TB) requires a comprehensive approach involving a combination of multiple drugs to effectively target the resistant bacteria. The World Health Organization (WHO) recommends a specific treatment regimen for MDR-TB, which involves the use of at least four drugs, including a fluoroquinolone and an injectable agent, for a minimum of 20 months.

**Why the Correct Answer is Right**
The correct answer, option C, reflects the WHO-recommended treatment regimen for MDR-TB. This regimen involves the use of six drugs for the initial 6 months, followed by four drugs for an additional 18 months. This prolonged treatment duration is necessary to ensure the eradication of the resistant bacteria. The use of multiple drugs, including a fluoroquinolone (such as ofloxacin) and an injectable agent (such as streptomycin), is critical in treating MDR-TB. These drugs work synergistically to target the resistant bacteria and prevent the development of further resistance.

**Why Each Wrong Option is Incorrect**
**Option A:** This option suggests using six drugs for 4 months followed by four drugs for 12 months. This regimen is too short and may not be effective in eradicating the resistant bacteria. The initial 4-month period is insufficient to achieve a significant reduction in bacterial load, and the subsequent 12-month period may not be long enough to ensure complete treatment.
**Option B:** This option suggests using four drugs for 4 months followed by six drugs for 12 months. This regimen is also too short and may not be effective in treating MDR-TB. The initial 4-month period is insufficient to achieve a significant reduction in bacterial load, and the subsequent 12-month period may not be long enough to ensure complete treatment.
**Option D:** This option suggests using five drugs for 2 months, followed by four drugs for 1 month, and then three drugs for 5 months. This regimen is too short and fragmented, and may not be effective in treating MDR-TB. The use of multiple drugs is critical in treating MDR-TB, and the prolonged treatment duration is necessary to ensure the eradication of the resistant bacteria.

**Clinical Pearl / High-Yield Fact**
It is essential to note that the treatment of MDR-TB requires a comprehensive approach, including regular monitoring of treatment response, adherence to the recommended treatment regimen, and close collaboration with healthcare professionals. Patients with MDR-TB require ongoing support and monitoring to ensure successful treatment outcomes.

**Correct Answer Line**
✓ Correct Answer: C. 6 drugs for 6 months; 4 drugs for 18 months